Mitsuru Ohsugi Selected Research

Mitsuru Ohsugi Research Topics

Disease

12	Type 2 Diabetes Mellitus (MODY) 07/2022 - 06/2006
11	Insulin Resistance 01/2019 - 02/2005
5	Insulinoma 07/2019 - 10/2002
5	Obesity 01/2019 - 02/2005
5	Glucose Intolerance 11/2014 - 06/2006
3	Inflammation (Inflammations) 04/2012 - 04/2011
3	Body Weight (Weight, Body) 01/2012 - 04/2007
2	Diabetes Complications 07/2022 - 07/2019
2	COVID-19 06/2022 - 06/2022
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2020 - 08/2020
2	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2012
1	Hemiplegia (Spastic Hemiplegia) 02/2022
1	Reperfusion Injury 02/2022
1	Hypoglycemia (Reactive Hypoglycemia) 02/2022
1	Hypercholesterolemia 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Renal cysts and diabetes syndrome 08/2020
1	Nausea 08/2020
1	Albuminuria 01/2020
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020
1	Lymphopenia (Lymphocytopenia) 07/2019
1	Wilms Tumor (Wilm's Tumor) 01/2018
1	Diabetes Mellitus 04/2014
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2012
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2012
1	Hypertrophy 10/2002

Drug/Important Bio-Agent (IBA)

13	Insulin (Novolin)FDA Link 07/2022 - 06/2004
13	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 10/2002
3	AdiponectinIBA 04/2011 - 04/2007
2	Hypoglycemic Agents (Hypoglycemics)IBA 07/2022 - 02/2020
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 06/2022 - 01/2020
2	Blood Glucose (Blood Sugar)IBA 06/2022 - 08/2020
2	Liraglutide FDA Link 08/2020 - 01/2012
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 02/2005
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2017 - 01/2012
2	Insulin ReceptorIBA 04/2011 - 02/2005
2	Phosphotransferases (Kinase)IBA 04/2011 - 10/2002
2	EnzymesIBA 06/2006 - 02/2005
2	Insulin Receptor Substrate ProteinsIBA 06/2006 - 02/2005
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Insulin Glargine (Lantus)FDA Link 08/2020
1	Glucagon-Like Peptide-1 ReceptorIBA 08/2020
1	Metformin (Glucophage)FDA LinkGeneric 02/2020
1	BiguanidesIBA 02/2020
1	Advanced Glycation End ProductsIBA 07/2019
1	AntigensIBA 07/2019
1	AutoantibodiesIBA 07/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	MethyltransferasesIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	glimepiride (Amarel)FDA LinkGeneric 01/2017
1	C-PeptideIBA 11/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2012
1	Pioglitazone (Actos)FDA Link 01/2012
1	ChemokinesIBA 04/2011
1	Class Ia Phosphatidylinositol 3-KinaseIBA 12/2010
1	AMP-Activated Protein KinasesIBA 01/2009
1	RimonabantIBA 01/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2007
1	AntibodiesIBA 06/2007
1	N-acetyltalosaminuronic acid (NAT)IBA 04/2007
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2006
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2006
1	U 0126 (UO 126)IBA 09/2006
1	Glycogen Synthase (Synthase I)IBA 04/2005
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2005
1	Small Interfering RNA (siRNA)IBA 02/2005
1	Acyl Coenzyme A (Acyl CoA)IBA 02/2005
1	Diacylglycerol O-AcyltransferaseIBA 02/2005
1	LeptinIBA 02/2005
1	Complementary DNA (cDNA)IBA 06/2004
1	Protein Kinases (Protein Kinase)IBA 10/2002

Therapy/Procedure

3	Glycemic Control 06/2022 - 07/2019
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2012
1	Percutaneous Coronary Intervention 03/2012